Explore Capital Management LLC Lowers Stock Holdings in Tenet Healthcare Corporation $THC

Explore Capital Management LLC reduced its position in Tenet Healthcare Corporation (NYSE:THC) by 56.1% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 22,100 shares of the company’s stock after selling 28,200 shares during the period. Tenet Healthcare comprises approximately 3.6% of Explore Capital Management LLC’s holdings, making the stock its 12th biggest holding. Explore Capital Management LLC’s holdings in Tenet Healthcare were worth $4,392,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Triumph Capital Management purchased a new stake in Tenet Healthcare in the 3rd quarter worth approximately $25,000. Activest Wealth Management purchased a new stake in Tenet Healthcare in the 4th quarter worth approximately $26,000. Elyxium Wealth LLC acquired a new position in shares of Tenet Healthcare in the 4th quarter valued at $29,000. Westside Investment Management Inc. boosted its holdings in shares of Tenet Healthcare by 100.0% in the 3rd quarter. Westside Investment Management Inc. now owns 192 shares of the company’s stock valued at $39,000 after purchasing an additional 96 shares during the last quarter. Finally, Canada Pension Plan Investment Board acquired a new position in shares of Tenet Healthcare in the 2nd quarter valued at $35,000. 95.44% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on the stock. Robert W. Baird decreased their price target on shares of Tenet Healthcare from $245.00 to $210.00 and set a “neutral” rating on the stock in a report on Tuesday, May 5th. Leerink Partners lifted their price target on shares of Tenet Healthcare from $255.00 to $264.00 and gave the company an “outperform” rating in a report on Friday, February 20th. Mizuho lifted their price target on shares of Tenet Healthcare from $235.00 to $265.00 and gave the company an “outperform” rating in a report on Thursday, March 12th. KeyCorp decreased their price target on shares of Tenet Healthcare from $250.00 to $225.00 and set an “overweight” rating on the stock in a report on Friday, May 1st. Finally, Guggenheim decreased their price target on shares of Tenet Healthcare from $283.00 to $252.00 and set a “buy” rating on the stock in a report on Friday, May 1st. Eighteen research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $244.16.

Insiders Place Their Bets

In other news, EVP Paola M. Arbour sold 6,500 shares of the firm’s stock in a transaction dated Wednesday, March 11th. The stock was sold at an average price of $238.43, for a total transaction of $1,549,795.00. Following the completion of the sale, the executive vice president directly owned 29,291 shares in the company, valued at $6,983,853.13. This trade represents a 18.16% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Thomas W. Arnst sold 8,000 shares of the firm’s stock in a transaction dated Monday, March 9th. The shares were sold at an average price of $238.85, for a total value of $1,910,800.00. Following the sale, the executive vice president owned 12 shares of the company’s stock, valued at $2,866.20. This represents a 99.85% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 23,138 shares of company stock valued at $4,976,589 over the last ninety days. Insiders own 0.97% of the company’s stock.

Tenet Healthcare Stock Down 2.4%

Shares of Tenet Healthcare stock opened at $160.87 on Friday. Tenet Healthcare Corporation has a twelve month low of $146.60 and a twelve month high of $247.21. The stock has a market cap of $13.86 billion, a price-to-earnings ratio of 8.37, a price-to-earnings-growth ratio of 1.08 and a beta of 1.28. The company has a current ratio of 1.36, a quick ratio of 1.30 and a debt-to-equity ratio of 1.96. The company has a fifty day moving average price of $186.93 and a 200 day moving average price of $201.02.

Tenet Healthcare (NYSE:THC) last issued its quarterly earnings data on Thursday, April 30th. The company reported $4.82 EPS for the quarter, topping analysts’ consensus estimates of $4.21 by $0.61. The firm had revenue of $5.37 billion for the quarter, compared to analyst estimates of $5.39 billion. Tenet Healthcare had a net margin of 7.94% and a return on equity of 25.55%. The firm’s revenue was up 2.6% compared to the same quarter last year. During the same quarter in the previous year, the business posted $4.36 EPS. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS. Equities research analysts forecast that Tenet Healthcare Corporation will post 17.67 earnings per share for the current fiscal year.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.